Transitioning our oncology pipeline
Aethel Oncology has successfully completed its acquisition phase. All active clinical protocols, investigational assets, and legacy research materials are transitioning to our global integration framework for continued development.
Targeted integration pathways
To maintain scientific continuity and clinical trial integrity, we have established direct routing channels. Please select the appropriate pathway below to ensure your request reaches the correct integration team.
Active Protocols
Legacy Research
Corporate Inquiries
All active clinical trial protocols are now managed under the acquiring entity's global operations. Authorized clinical investigators should contact the coordinating office for transition support and protocol updates.
Requests for historical clinical trial data, preclinical study archives, and regulatory documentation must be submitted formally. All legacy databases remain archived under strict compliance standards.
Former shareholders, media representatives, and industry partners requiring transaction details, press kits, or corporate integration updates can access dedicated communication channels here.
Submit formal inquiry
Please utilize this secure portal to submit formal inquiries directly to the transition office. All submissions are routed based on inquiry type to expedite response times.